eClinics
Ceiba Healthcare US, Inc. · Decision date Oct 7, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for eClinics, a Ceiba Healthcare US, Inc. submission, on October 7, 2026, under 510(k) number K260075. The device is classified under 21 CFR 870.2300 as a Cardiac Monitor (Including Cardiotachometer And Rate Alarm), Class II, product code MSX, in the Cardiovascular panel. The summary names AirStrip ONE Web Client with ACM (K211949) as the predicate. SESE means clearance to market, not premarket approval.
The cleared indications describe software that lets trained healthcare professionals capture and display waveforms such as ECG, SpO2 and ART, discrete parameters, demographics and alarms from connected devices and electronic health record systems on centralized multi-patient views, as a diagnostic aid when staff cannot observe the source system directly. The summary lists modules including CMS Prime, CMS Telemetry, Population Management, Patient Timeline, Blood Gas, Laboratory Results, Flowsheets and Order Management. The public record does not state performance testing results or the full comparison to the predicate beyond the summary table.
The record shows conflicting dates and addresses: the decision letter is dated October 7, 2026, while the database lists a January 12, 2026 receipt date and the letter cites September 11, 2026; applicant addresses and the representative's name also differ between documents. These discrepancies are unresolved in the public information.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 7, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260075
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Ceiba Healthcare US, Inc.
- Product code
- MSX
- Decision code
- SESE
- Decision date
- Oct 7, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Network And Communication, Physiological Monitors.
- Applicant
- Ceiba Healthcare US, Inc.
- Product code
- MSX
- FDA device class
- 2
FDA decision timeline
K260075 received
Application receipt date recorded by FDA.
K260075 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MSX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Digistat CareK261287 | Ascom Ums Srl Unipersonale | 510(k) clearance | Sep 12, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Ceiba Healthcare US, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- New York, NY
Sources and methodology
- Original FDA record: K260075
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records